These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 24059332)

  • 1. Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions.
    Imberdis T; Ayrolles-Torro A; Verdier JM; Perrier V
    Curr Top Med Chem; 2013; 13(19):2477-83. PubMed ID: 24059332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transmissible spongiform encephalopathies of livestock.
    Greenlee JJ; Greenlee MH
    ILAR J; 2015; 56(1):7-25. PubMed ID: 25991695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prion diseases or transmissible spongiform encephalopathies].
    Brandel JP
    Rev Med Interne; 2022 Feb; 43(2):106-115. PubMed ID: 34148672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease.
    Sikorska B; Liberski PP
    Subcell Biochem; 2012; 65():457-96. PubMed ID: 23225013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
    Imberdis T; Ayrolles-Torro A; Duarte Rodrigues A; Torrent J; Alvarez-Martinez MT; Kovacs GG; Verdier JM; Robitzer M; Perrier V
    Mol Neurodegener; 2016 Jan; 11():11. PubMed ID: 26809712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics studies on the buffalo prion protein.
    Zhang J; Wang F; Chatterjee S
    J Biomol Struct Dyn; 2016; 34(4):762-77. PubMed ID: 26043781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seeded fibrillation as molecular basis of the species barrier in human prion diseases.
    Luers L; Bannach O; Stöhr J; Wördehoff MM; Wolff M; Nagel-Steger L; Riesner D; Willbold D; Birkmann E
    PLoS One; 2013; 8(8):e72623. PubMed ID: 23977331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raccoons accumulate PrP
    Moore SJ; Smith JD; Richt JA; Greenlee JJ
    J Vet Diagn Invest; 2019 Mar; 31(2):200-209. PubMed ID: 30694116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion disease: a deadly disease for protein misfolding.
    Chakraborty C; Nandi S; Jana S
    Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep.
    Lim K; Kim SY; Lee B; Segarra C; Kang S; Ju Y; Schmerr MJ; Coste J; Kim SY; Yokoyama T; An SS
    Int J Nanomedicine; 2015; 10(Spec Iss):241-50. PubMed ID: 26425091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity.
    Ayrolles-Torro A; Imberdis T; Torrent J; Toupet K; Baskakov IV; Poncet-Montange G; Grégoire C; Roquet-Baneres F; Lehmann S; Rognan D; Pugnière M; Verdier JM; Perrier V
    J Neurosci; 2011 Oct; 31(42):14882-92. PubMed ID: 22016521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies.
    Hainfellner JA; Budka H
    Acta Neuropathol; 1999 Nov; 98(5):458-60. PubMed ID: 10541867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.